Translate
Jasper Therapeutics Inc
About
Jasper Therapeutics Inc (NASDAQ:JSPR) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 30 2026
Jasper Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Corporate Update
Feb 24 2026
Jasper Therapeutics to Present at 46th Annual TD Cowen Healthcare Conference
Jan 8 2026
Jasper Therapeutics Reports Positive Updated Data from Briquilimab Studies in Chronic Spontaneous Urticaria
Jan 7 2026
Jasper Therapeutics Appoints Jeet Mahal as Chief Executive Officer to Lead Next Phase of Clinical Growth
Dec 2 2025
Jasper Therapeutics Reports Positive Preliminary Data from ETESIAN Study of Briquilimab in Asthma and Findings from BEACON Study Internal Investigation
Recent Videos
My Insight: Jasper Therapeutics' Leadership Shake Up
Jan 11, 2026
My Insight on Jasper Therapeutics' Clinical Trial Update
Jan 09, 2026
Jasper Therapeutics Positive Updated Data from Briquilimab Studies in Chronic Spontaneous Urticaria
Jan 09, 2026
Jasper Therapeutics Positive Preliminary Data from ETESIAN Study of Briquilimab in Asthma
Dec 04, 2025